Cargando…

Topoisomerase Inhibitors Have Potent Differentiation‐inducing Activity for Human and Mouse Myeloid Leukemia Cells

DNA topoisomerase inhibitors, camptothecin and 4′‐demethylepipodophyllotoxin ethylidene‐jS‐D‐glucoside (VP16) had strong differentiation‐inducing activity for all five kinds of leukemia cells examined (human HL60, U937, ML1, and K562 cells and mouse Ml cells) as judged from measurements of various d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakaya, Kazuyasu, Chou, Sawako, Kaneko, Motohisa, Nakamura, Yasuharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1991
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918380/ https://www.ncbi.nlm.nih.gov/pubmed/1848545 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01827.x

Ejemplares similares

Tumor Necrosis Factor Changes Sensitivity of Differentiation of Mouse Leukemia M1 Cells by Lipopolysaccharide
por: Nakaya, Kazuyasu, et al.
Publicado: (1990)

ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia
por: Zhou, Jianbiao, et al.
Publicado: (2019)

β‐Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases
por: Hashimoto, Sachiko, et al.
Publicado: (2002)

Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
por: Halbach, Sebastian, et al.
Publicado: (2016)

Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia
por: Michelson, Andrew P., et al.
Publicado: (2020)

The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison
por: Cowell, Ian G., et al.
Publicado: (2019)

Induction of Differentiation of Mouse Myeloid Leukemia M1 Cells by Serum of Patients with Chronic Myeloid Leukemia
por: Okabe‐Kado, Junko, et al.
Publicado: (1988)

Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia
por: Branstrom, Arthur, et al.
Publicado: (2022)

Tumor Necrosis Factor‐inducing Activities of Lipid A Preparations from Pseudomonas diminuta and Pseudomonas vesicularis
por: Arata, Satoru, et al.
Publicado: (1988)

Myeloid hyperplasia in the SENCAR mouse: differentiation from granulocytic leukemia.
por: Long, R E, et al.
Publicado: (1986)

Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia
por: Zhang, Yvyin, et al.
Publicado: (2023)

Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
por: Gaur, Tarang, et al.
Publicado: (2023)

Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β
por: Ortega, Jose Antonio, et al.
Publicado: (2020)

lncRNA requirements for mouse acute myeloid leukemia and normal differentiation
por: Delás, M Joaquina, et al.
Publicado: (2017)

Mechanism of action of non-camptothecin inhibitor Genz-644282 in topoisomerase I inhibition
por: Nishida, Masahiro, et al.
Publicado: (2022)

Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor
por: Ezoe, Sachiko
Publicado: (2012)

Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells
por: Wang, Meichen, et al.
Publicado: (2023)

Topoisomerase inhibitors suppressed lithocholic acid-induced promotion of transformation in BALB/3T3.
por: Kaneko, M., et al.
Publicado: (1987)

Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress
por: Doshi, Kshama A., et al.
Publicado: (2016)

Regulation of the expression of vimentin gene during the differentiation of mouse myeloid leukemia cells
Publicado: (1990)

The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV
por: Kokot, Maja, et al.
Publicado: (2022)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

Lapcin, a potent dual topoisomerase I/II inhibitor discovered by soil metagenome guided total chemical synthesis
por: Wang, Zongqiang, et al.
Publicado: (2022)

HDAC Inhibitors in Acute Myeloid Leukemia
por: San José-Enériz, Edurne, et al.
Publicado: (2019)

Checkpoint Inhibitors in Acute Myeloid Leukemia
por: Damiani, Daniela, et al.
Publicado: (2023)

Differential regulation of NF-κB activation and function by topoisomerase II inhibitors
por: Campbell, Kirsteen J, et al.
Publicado: (2006)

Hyperthermia, thermotolerance and topoisomerase II inhibitors.
por: Kampinga, H. H.
Publicado: (1995)

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
por: Mori, Masamichi, et al.
Publicado: (2017)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia
por: Sun, Yinghui, et al.
Publicado: (2017)

Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
por: Huang, Yahui, et al.
Publicado: (2020)

Therapy-related acute leukemia in breast cancer patients: twelve cases treated with a topoisomerase inhibitor
por: Shim, Hyoeun, et al.
Publicado: (2010)

Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice
por: Naganna, N., et al.
Publicado: (2019)

CDK9 inhibitors in acute myeloid leukemia
por: Boffo, Silvia, et al.
Publicado: (2018)

FLT3 inhibitors in acute myeloid leukemia
por: Wu, Mei, et al.
Publicado: (2018)

Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
por: Liu, Xiaoyan, et al.
Publicado: (2019)

Mechanisms regulating resistance to inhibitors of topoisomerase II
por: Ganapathi, Ram N., et al.
Publicado: (2013)

Dual Inhibitors Against Topoisomerases and Histone Deacetylases
por: Seo, Young Ho
Publicado: (2015)

Potent Anti-Ovarian Cancer with Inhibitor Activities on Both Topoisomerase II and (V600E)BRAF of Synthesized Substituted Estrone Candidates
por: El-Naggar, Mohamed, et al.
Publicado: (2019)

Chronic myeloid leukemia in children, do we have all the answers?
por: Bansal, Shweta
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7bhk7ush928opebgu07jpj40l4